Several studies have estimated health state utilities for patients with schizophrenia according to disease stage. However, the quality of life of these patients is also largely dependent on treatment-related adverse events, and there is paucity of data on utilities associated with those adverse events. The objective of this study was to estimate utility decrements associated with treatment-related adverse events in patients with schizophrenia, using data from an observational study.